Seosaph has launched PortiVix, the next-generation version of its Pharma Project & Portfolio Management (PPM) platform, as part of the debut of VirtuNx, the company’s dedicated enterprise product organization.
Evolved from Seosaph’s flagship SEOPRO platform, PortiVix is designed to help pharmaceutical companies manage increasingly complex R&D pipelines, regulatory requirements, and portfolio priorities through a unified platform for project execution, portfolio oversight, governance, strategic prioritization, and decision intelligence.
Already adopted by leading pharmaceutical organizations, the platform has been developed through continuous customer collaboration and industry-driven innovation.
“PortiVix reflects our long-term vision of helping pharmaceutical organizations navigate increasing complexity with greater intelligence, confidence, and agility,” said Nagarajan Selvaraj, CEO of Seosaph.
According to Phanindra Venkata, CEO of VirtuNx and Business Head at Seosaph, PortiVix goes beyond conventional project management by enabling organizations to make better portfolio decisions through a connected ecosystem.
Purpose-built for the pharmaceutical industry, the platform enhances visibility across projects, resources, governance, and strategic priorities, enabling informed decision-making throughout the portfolio lifecycle.
Seosaph said the launch reinforces its commitment to delivering AI-driven enterprise solutions that help regulated industries transform operational complexity into data-driven business decisions.
